Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oncological emergencies.
Cervantes A, Chirivella I. Cervantes A, et al. Among authors: chirivella i. Ann Oncol. 2004;15 Suppl 4:iv299-306. doi: 10.1093/annonc/mdh943. Ann Oncol. 2004. PMID: 15477325 Free article. Review. No abstract available.
[Neoadjuvant therapy for operable breast-cancer].
Insa A, Chirivella I, Lluch A. Insa A, et al. Among authors: chirivella i. Med Clin (Barc). 2006 Mar 4;126(8):295-303. doi: 10.1157/13085484. Med Clin (Barc). 2006. PMID: 16527157 Review. Spanish.
A multimodality approach to localized rectal cancer.
Cervantes A, Chirivella I, Rodriguez-Braun E, Campos S, Navarro S, García Granero E. Cervantes A, et al. Among authors: chirivella i. Ann Oncol. 2006 Sep;17 Suppl 10:x129-34. doi: 10.1093/annonc/mdl250. Ann Oncol. 2006. PMID: 17018713 Free article. Review. No abstract available.
Parotid gland metastasis of a breast cancer.
Perez-Fidalgo JA, Chirivella I, Laforga J, Colio JM, Blanes MD, Baydal R, Roselló S, De-la-Morena E, Lluch A. Perez-Fidalgo JA, et al. Among authors: chirivella i. Clin Transl Oncol. 2007 Apr;9(4):264-5. doi: 10.1007/s12094-007-0051-2. Clin Transl Oncol. 2007. PMID: 17462982
Polymorphisms in TRAIL receptor genes and risk of breast cancer in Spanish women.
Martinez-Ferrandis JI, Rodríguez-López R, Milne RL, González E, Cebolla E, Chirivella I, Zamora P, Arias JI, Palacios S, Cervantes A, Díez O, Benitez J, Armengod ME. Martinez-Ferrandis JI, et al. Among authors: chirivella i. Cancer Biomark. 2007;3(2):89-93. doi: 10.3233/cbm-2007-3203. Cancer Biomark. 2007. PMID: 17522430
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.
Milne RL, Osorio A, Cajal TR, Vega A, Llort G, de la Hoya M, Díez O, Alonso MC, Lazaro C, Blanco I, Sánchez-de-Abajo A, Caldés T, Blanco A, Graña B, Durán M, Velasco E, Chirivella I, Cardeñosa EE, Tejada MI, Beristain E, Miramar MD, Calvo MT, Martínez E, Guillén C, Salazar R, San Román C, Antoniou AC, Urioste M, Benítez J. Milne RL, et al. Among authors: chirivella i. Clin Cancer Res. 2008 May 1;14(9):2861-9. doi: 10.1158/1078-0432.CCR-07-4436. Clin Cancer Res. 2008. PMID: 18451254
Biweekly cetuximab and irinotecan in advanced colorectal cancer patients progressing after at least one previous line of chemotherapy: results of a phase II single institution trial.
Martín-Martorell P, Roselló S, Rodríguez-Braun E, Chirivella I, Bosch A, Cervantes A. Martín-Martorell P, et al. Among authors: chirivella i. Br J Cancer. 2008 Aug 5;99(3):455-8. doi: 10.1038/sj.bjc.6604530. Br J Cancer. 2008. PMID: 18665167 Free PMC article. Clinical Trial.
59 results